Table 1.

The Clinical Characteristic of the Patients Included in the Study

	Etanercept Group (39 pts)	Adalimumab Group (29 pts)	Infliximab Group (21 pts)
Age mean years	59.6±9.8	58.7±10.6	60.1±9.3
Disease mean	8.4±3.2	8.2±4.2	8.5±4.1
Female/Male	33/6	25/4	19/2
Corticosteroid dose mg	5.2±2.1	4.8±2.2	4.9±2.2
Methotrexate dose mg/w	11.5±3.6	12.6±2.5	12.7±2.3
RF positive	67%	68%	66%
Anti CC-P positive	83%	81%	80%
DAS28	4.8±1.4	4.7±1.6	4.6±1.5
ESR mm/h	49.3±12.5	51.2±9.6	51.6±9.9
CRP mg/dl	3.2±1.4	3.3±1.6	3.1±1.8